Merck & Co Inc (LTS:0QAH)
$ 131.3 0 (0%) Market Cap: 249.37 Bil Enterprise Value: 272.91 Bil PE Ratio: 20.67 PB Ratio: 5.61 GF Score: 81/100

Merck & Co Inc at Cowen HealthCare Conference Transcript

Mar 03, 2020 / 05:00PM GMT
Release Date Price: $77.06 (-0.13%)
Stephen Michael Scala
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Well, hello once again. We're very, very happy to have Merck with us at the Cowen Conference again this year. Representing the company is Rob Davis, Chief Financial Officer; as well as Peter Dannenbaum, who heads up the Investor Relations effort.

So thank you so much for being with us today.

Questions & Answers

Stephen Michael Scala
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

So given the fact that it's Super Tuesday, I thought I would start out with a bit of a pricing question, and maybe you could just articulate for us how pricing has trended over the last 3 years, how you look at it over the next 3 years, and does it change -- does the answer change if Bernie Sanders is the next president?

Robert M. Davis
Merck & Co., Inc. - Executive VP of Global Services & CFO

Well, if you look at where we've been, and we've talked about this in the past, obviously,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot